NASDAQ: NGNE
Neurogene Inc Stock Ownership - Who owns Neurogene?

Insider buying vs selling

Have Neurogene Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Stuart CobbChief Scientific Officer2025-05-146,797$15.15
$103.00kSell
Christine Mikail CvijicPresident and CFO2025-03-134,501$16.94
$76.25kSell
Samsara Biocapital GP LLC10% Owner2024-11-2620,748$24.91
$516.83kBuy
Samsara Biocapital GP LLC10% Owner2024-11-2615,219$26.73
$406.80kBuy
Samsara Biocapital GP LLC10% Owner2024-11-2610,803$26.01
$280.99kBuy
Samsara Biocapital GP LLC10% Owner2024-11-262,000$27.50
$55.00kBuy
Rachel McMinnChief Executive Officer2024-11-2247,500$20.40
$969.00kBuy
Christine Mikail CvijicPresident and CFO2024-11-2224,000$20.48
$491.40kBuy

1 of 1

NGNE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NGNE insiders and whales buy or sell their stock.

NGNE Shareholders

What type of owners hold Neurogene Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC27.11%3,866,579$69.75MInsider
Jonathan G. Drachman16.12%2,298,686$41.47MInsider
Gary Bridger13.48%1,922,775$34.69MInsider
Samsara Biocapital LLC12.04%1,717,127$30.98MInstitution
Samsara Biocapital GP LLC11.70%1,668,357$30.10MInsider
Ventures West 8 Limited Partnership10.83%1,543,989$27.85MInsider
Baker Bros Advisors LP10.42%1,486,200$26.81MInstitution
Johnson Johnson10.11%1,442,094$26.02MInsider
Blackrock Inc9.81%1,399,133$25.24MInstitution
Carl Walkey9.48%1,352,489$24.40MInsider

1 of 3

NGNE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NGNE48.01%51.99%Net BuyingNet Selling
AVIR61.74%25.13%Net Selling
GLUE33.05%66.95%Net SellingNet Buying
ADCT55.30%43.21%Net BuyingNet Selling
TVGN2.09%85.95%Net SellingNet Selling

Neurogene Stock Ownership FAQ

Who owns Neurogene?

Neurogene (NASDAQ: NGNE) is owned by 115.39% institutional shareholders, 124.95% Neurogene insiders, and 0.00% retail investors. Redmile Group LLC is the largest individual Neurogene shareholder, owning 3.87M shares representing 27.11% of the company. Redmile Group LLC's Neurogene shares are currently valued at $66.81M.

If you're new to stock investing, here's how to buy Neurogene stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.